Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Biotechnology|October 15, 2014
Polyphenols in disease: from diet to supplementsRamon Rodrigo, Matias Libuy, Felipe Feliu, et al.
Current Topics in Medicinal Chemistry|April 28, 2015
Cardiovascular Disease: A Target for the Pharmacological Effects of QuercetinJuan Guillermo Gormaz, Sebastian Quintremil, Ramon Rodrigo
Disease Markers|December 19, 2013
Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damageRamón Rodrigo, Matías Libuy, Felipe Feliú, et al.
Biomed Research International|August 13, 2013
Molecular basis of cardioprotective effect of antioxidant vitamins in myocardial infarctionRamón Rodrigo, Matías Libuy, Felipe Feliú, et al.
Case Reports in Urology|December 1, 2022
Intranodal Ultrasound-Guided Percutaneous Methylene Blue Injection for the Identification of Leakage Point during Laparoscopic Repair of Refractory Chylous Ascites after Laparoscopic Lymphadenectomy for Kidney CancerHugo Otaola-Arca, Patricio Vargas, Daniel Hasson, et al.
Andes Pediatrica : Revista Chilena De Pediatria|June 9, 2021
Minimally invasive therapy for the resolution of a subcapsular hepatic hematoma in a newbornMaría Santos C, Gian Paolo Zamboni T, Daniel Hasson, et al.
Trials|June 3, 2014
The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trialRamón Rodrigo, Daniel Hasson, Juan C Prieto, et al.
Journal of Visualized Experiments : Jove|May 29, 2023
Non-Aqueous Isolation and Enrichment of Glandular Capitate Stalked and Sessile Trichomes from Cannabis sativaShahar Cohen, Maxim Itkin, Adi Faigenboim, et al.
Redox Report : Communications in Free Radical Research|June 13, 2015
Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarctionNicolás Valls, Juan G Gormaz, Rubén Aguayo, et al.
Trials|February 6, 2020
Prevention of doxorubicin-induced Cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning based on Docosahexaenoic Acid (DHA) and carvedilol direct antioxidant effects: study protocol for a pilot, randomized, double-blind, controlled trial (CarDHA trial)Rodrigo Carrasco, María Cristina Ramirez, Kjersti Nes, et al.
Pageof 2